USANA Health Sciences earnings report: Investors prepare 2023

USANA Health Sciences (NYSE: USNA) will report its highly anticipated earnings on Tuesday, April 25th, after the market closes. Analysts expect $0.77 per share in quarterly earnings. Investors and market observers eagerly await this key data that will likely affect USANA’s stock.

DA Davidson raised their price objective from $49.00 to $52.50 and gave the stock a “neutral” rating on February 13th. USANA Health Sciences was upgraded a “strong-buy” by on March 10.

USANA’s earnings forecast is mixed, but numerous insiders have sold shares. In February, Brent Neidig sold 1,872 shares at $61.89 and Joshua Foukas sold 3,771 at $61.01.

In three months, company insiders sold 24,632 shares for over $1.4 million.However, insiders still own 0.33% of USANA stock, signaling optimism about its long-term potential.

Insider sales may indicate a loss of faith or just take advantage of high stock prices, making investors apprehensive before making final decisions, especially with news cycles becoming more unpredictable.

All signs point to this week’s results call providing shareholders and financial analysts with valuable insights into the pioneering health science company’s Q2 and beyond plans.

USANA Health Sciences Earns Big Quarterly, Draws Institutional Investors

USANA Health Sciences (NYSE:USNA) published its quarterly earnings, delighting shareholders. USANA reported earnings per share of $0.66, beating analysts’ consensus by 31 cents, and expects to continue this success with projected $3 EPS for both the current and next fiscal years. Revenue reached $227.96 million, and return on equity was 16.92%. USNA shares began at $64.15 on Tuesday, increasing steadily from a 1-year low of $48.61.

Many institutional investors and hedge funds have changed their USNA investments due to this stock price rise. Point72 Hong Kong Ltd bought a $69,000 position, while Covestor Ltd bought 446 shares to increase its holdings by 92.7% in the first quarter.

In the third quarter, Captrust Financial Advisors grew its USANA Health Sciences holdings by 104.6%, while Tower Research Capital LLC TRC expanded its holdings by a stunning 290%, indicating investor confidence in USNA’s performance.

After increasing their holdings by 98.9% in Q4, Advisor Group Holdings Inc. added 910 more shares.

Institutional investors and hedge funds own nearly half of USNA’s shares, indicating that they too are seeing the benefits of investing in USANA Health Sciences.

Even if markets like NYSE:USNA have ups and downs, people will always hunt for chances. However, investors must investigate their investments to comprehend the risks.

You May Also Like

About the Author: Sanjh Vishwakarma

Leave a Reply